Legal Update, October 2020

HTCs often inquire with the Hemophilia Alliance regarding what is an appropriate “indirect cost rate.”

Legal Update, September 2020

Under the auspices of 340B Program compliance, manufacturers recently requested extensive data from covered entities related to drugs dispensed through contract pharmacies.

Legal Update, August 2020

Under the auspices of 340B Program compliance, manufacturers recently requested extensive data from covered entities related to drugs dispensed through contract pharmacies.

Legal Update, Hill Day 2020

In recent weeks, three drug manufacturers have taken unprecedented actions that threaten covered entity participation in the 340B Discount Drug Pricing Program (340B Program).